These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25251201)

  • 21. A randomized trial of combined citalopram and naltrexone for nonabstinent outpatients with co-occurring alcohol dependence and major depression.
    Adamson SJ; Sellman JD; Foulds JA; Frampton CM; Deering D; Dunn A; Berks J; Nixon L; Cape G
    J Clin Psychopharmacol; 2015 Apr; 35(2):143-9. PubMed ID: 25679122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naltrexone treatment of comorbid alcohol and cocaine use disorders.
    Hersh D; Van Kirk JR; Kranzler HR
    Psychopharmacology (Berl); 1998 Sep; 139(1-2):44-52. PubMed ID: 9768541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of naltrexone on cue-elicited craving for alcohol and cocaine.
    Modesto-Lowe V; Burleson JA; Hersh D; Bauer LO; Kranzler HR
    Drug Alcohol Depend; 1997 Dec; 49(1):9-16. PubMed ID: 9476694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients.
    Pettinati HM; Volpicelli JR; Pierce JD; O'Brien CP
    J Addict Dis; 2000; 19(1):71-83. PubMed ID: 10772604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose naltrexone therapy for cocaine-alcohol dependence.
    Schmitz JM; Lindsay JA; Green CE; Herin DV; Stotts AL; Moeller FG
    Am J Addict; 2009; 18(5):356-62. PubMed ID: 19874153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community.
    Springer SA; Altice FL; Herme M; Di Paola A
    Contemp Clin Trials; 2014 Mar; 37(2):209-18. PubMed ID: 24384538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence.
    Brown ES; Carmody TJ; Schmitz JM; Caetano R; Adinoff B; Swann AC; John Rush A
    Alcohol Clin Exp Res; 2009 Nov; 33(11):1863-9. PubMed ID: 19673746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial.
    Galloway GP; Koch M; Cello R; Smith DE
    BMC Psychiatry; 2005 Apr; 5():18. PubMed ID: 15804355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended-release naltrexone for methamphetamine dependence among men who have sex with men: a randomized placebo-controlled trial.
    Coffin PO; Santos GM; Hern J; Vittinghoff E; Santos D; Matheson T; Colfax G; Batki SL
    Addiction; 2018 Feb; 113(2):268-278. PubMed ID: 28734107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bupropion and Naltrexone in Methamphetamine Use Disorder.
    Trivedi MH; Walker R; Ling W; Dela Cruz A; Sharma G; Carmody T; Ghitza UE; Wahle A; Kim M; Shores-Wilson K; Sparenborg S; Coffin P; Schmitz J; Wiest K; Bart G; Sonne SC; Wakhlu S; Rush AJ; Nunes EV; Shoptaw S
    N Engl J Med; 2021 Jan; 384(2):140-153. PubMed ID: 33497547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-acting injectable naltrexone for the treatment of alcohol dependence.
    Mannelli P; Peindl K; Masand PS; Patkar AA
    Expert Rev Neurother; 2007 Oct; 7(10):1265-77. PubMed ID: 17939765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness.
    Krupitsky E; Nunes EV; Ling W; Gastfriend DR; Memisoglu A; Silverman BL
    Addiction; 2013 Sep; 108(9):1628-37. PubMed ID: 23701526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome predictors for problem drinkers treated with combined cognitive behavioral therapy and naltrexone.
    Vuoristo-Myllys S; Lipsanen J; Lahti J; Kalska H; Alho H
    Am J Drug Alcohol Abuse; 2014 Mar; 40(2):103-10. PubMed ID: 24456403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence.
    O'Brien CP
    Curr Psychiatry Rep; 2005 Oct; 7(5):327-8. PubMed ID: 16216149
    [No Abstract]   [Full Text] [Related]  

  • 36. Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.
    Oslin DW; Leong SH; Lynch KG; Berrettini W; O'Brien CP; Gordon AJ; Rukstalis M
    JAMA Psychiatry; 2015 May; 72(5):430-7. PubMed ID: 25760804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot evaluation of the safety and tolerability of repeat dose administration of long-acting injectable naltrexone (Vivitrex) in patients with alcohol dependence.
    Johnson BA; Ait-Daoud N; Aubin HJ; Van Den Brink W; Guzzetta R; Loewy J; Silverman B; Ehrich E
    Alcohol Clin Exp Res; 2004 Sep; 28(9):1356-61. PubMed ID: 15365306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence.
    Colagiuri B; Morley K; Boakes R; Haber P
    Psychother Psychosom; 2009; 78(3):167-71. PubMed ID: 19270472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomized trial].
    Krupitskiĭ EM; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Blokhina EA; Silverman BL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5 Pt 2):3-11. PubMed ID: 22951790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.
    Dürsteler-MacFarland KM; Farronato NS; Strasser J; Boss J; Kuntze MF; Petitjean SA; Bürki C; Wiesbeck GA
    J Clin Psychopharmacol; 2013 Feb; 33(1):104-8. PubMed ID: 23277248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.